SMN2 and proximal spinal muscular atrophy: Contrary to SMN-ASO, which could be developed and then used in both, SMA mice which carry the human SMN2 gene and in SMA patients [49,56,57], the orthologous NCALD genes differ between mice and humans and therefore, human-specific NCALD-ASO had to be developed and tested.